Fortem Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
1,577
+22
+1% +$22.5K 0.39% 68
2026
Q1
$1.43M Buy
1,555
+58
+4% +$58.8K 0.36% 68
2025
Q4
$1.61M Sell
1,497
-41
-3% -$39.2K 0.43% 61
2025
Q3
$1.17M Sell
1,538
-537
-26% -$400K 0.34% 70
2025
Q2
$1.62M Buy
2,075
+55
+3% +$42.7K 0.52% 56
2025
Q1
$1.67M Buy
2,020
+14
+0.7% +$11.6K 0.65% 41
2024
Q4
$1.55M Sell
2,006
-32
-2% -$26.5K 0.6% 42
2024
Q3
$1.81M Buy
2,038
+390
+24% +$351K 0.73% 36
2024
Q2
$1.49M Sell
1,648
-67
-4% -$53.6K 0.64% 45
2024
Q1
$1.33M Sell
1,715
-46
-3% -$32.7K 0.59% 58
2023
Q4
$1.03M Buy
1,761
+100
+6% +$58.4K 0.51% 64
2023
Q3
$892K Sell
1,661
-32
-2% -$16.5K 0.52% 60
2023
Q2
$794K Sell
1,693
-91
-5% -$38.2K 0.47% 74
2023
Q1
$613K Sell
1,784
-1,193
-40% -$402K 0.4% 87
2022
Q4
$1.09M Sell
2,977
-30
-1% -$10.6K 0.64% 47
2022
Q3
$972K Sell
3,007
-46
-2% -$14.6K 0.67% 51
2022
Q2
$990K Sell
3,053
-14,929
-83% -$4.48M 0.65% 52
2022
Q1
$5.15M Buy
17,982
+622
+4% +$160K 2.25% 3
2021
Q4
$4.79M Buy
17,360
+433
+3% +$110K 2.19% 3
2021
Q3
$3.91M Buy
16,927
+266
+2% +$65.7K 1.98% 5
2021
Q2
$3.82M Buy
16,661
+1,228
+8% +$247K 1.94% 7
2021
Q1
$2.88M Sell
15,433
-453
-3% -$88.6K 1.67% 11
2020
Q4
$2.68M Buy
15,886
+307
+2% +$45.8K 1.61% 10
2020
Q3
$2.31M Buy
15,579
+10,932
+235% +$1.69M 1.67% 12
2020
Q2
$763K Sell
4,647
-222
-5% -$34.1K 0.59% 58
2020
Q1
$675K Sell
4,869
-1,917
-28% -$263K 0.62% 62
2019
Q4
$892K Buy
6,786
+1,449
+27% +$168K 0.66% 59
2019
Q3
$597K Buy
5,337
+3,321
+165% +$370K 0.51% 75
2019
Q2
$223K Buy
2,016
+264
+15% +$31.1K 0.22% 104
2019
Q1
$227K Buy
+1,752
New +$213K 0.24% 98

Other funds holding LLY

Fortem Financial Group's LLY Position: Q2 2026 in Review

Fortem Financial Group increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,577 shares worth $1.89M. The position accounts for 0.39% of the portfolio, ranked #68.

Fortem Financial Group first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.15M in Q1 2022. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fortem Financial Group held 1,577 shares of Eli Lilly worth $1.89M as of Q2 2026.
  • Fortem Financial Group bought 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.39% of Fortem Financial Group's portfolio in Q2 2026, its #68 holding.
  • Fortem Financial Group first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
  • Fortem Financial Group's Eli Lilly position peaked at $5.15M in Q1 2022.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fortem Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.